A recent investigation revealed that the Tregs/CD4+ percentage in the blood of ARDS patients was significantly higher compared to non-ARDS patients, while the Tregs/CD4+ percentage in the lung alveoli was lower (69). This evidence concerns the gene CD4 and acute respiratory distress syndrome.